Browsing by Subject infectious diseases
Showing results 1 to 8 of 8
| Issue Date | Title | Author(s) |
|---|---|---|
| 22-Jan-2025 | Clinical Characteristics of Virologically Confirmed Respiratory Syncytial Virus in English Primary Care: Protocol for an Observational Study of Acute Respiratory Infection | Hoang, U; Agrawal, U; Ordóñez-Mena, JM; Marcum, Z; Radin, J; Araujo, A; Panozzo, CA; Balogh, O; Desai, M; Eltayeb, A; Lu, T; Nicodemo, C; Gu, X; Goudie, R; Fan, X; Button, E; Smylie, J; Joy, M; Jamie, G; Elson, W; Byford, R; Madia, J; Anand, S; Ferreira, F; Petrou, S; Martin, D; de Lusignan, S |
| 22-May-2023 | Depression and anxiety during and after episodes of COVID-19 in the community | Alacevich, C; Thalmann, I; Nicodemo, C; de Lusignan, S; Petrou, S |
| 11-Jul-2018 | The impact of community-based health insurance on the utilization of medically trained healthcare providers among informal workers in Bangladesh | Sarker, AR; Sultana, M; Chakrovorty, S; Ahmed, MW; Dorin, F; Mirelman, AJ; Islam, Z; Rahman, MH; Niessen, LW; Rehnberg, C; Khan, JAM |
| 22-Feb-2021 | The impact of uncertainty on predictions of the CovidSim epidemiological code | Edeling, W; Arabnejad, H; Sinclair, R; Suleimenova, D; Gopalakrishnan, K; Bosak, B; Groen, D; Mahmood, I; Crommelin, D; Coveney, PV |
| 18-Jan-2021 | Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19 | Kyrou, I; Randeva, HS; Spandidos, DA; Karteris, E |
| 16-Oct-2025 | Self-reported poliomyelitis vaccination and documentation in adults indicates high uptake: a digital German epidemic panel, December 2024 | Kettlitz, R; Harries, M; Contreras, S; Reinecke, J; Wieder, MS; von Lengerke, T; Castell, S; Lange, B; Klett-Tammen, CJ; Melhorn, V; Schulze, DA; Helmholtz, FJ; Rodiah, I; Shomali, K; Montresor, G; Leardini, C; Landi, S; Bucciol, A; Nicodemo, C; Garcia-Guerrero, MC; Puertas, MC; Morón-López, S; Fernández-Rosas, E; Martinez-Picado, J; De Groote, R; Van Hileghem, L; Spasic, D; Lammertyn, J; Ma, Z; Fritz, G; Bayoumi, MMA; Kayahan, E; Solvas, XCI; Ziemons, GRM; Klopp, N; Illig, T; Kern, WV; Kappert, O; Tonn, T; Gubbe, K; Frank, K; Bojara, G; Kerrinnes, T; Schlüter, M; Gornyk, D; Hernandez, P; Krause, G; Heise, JK; Schneiderhan-Marra, N; Dulovic, A; Strengert, M; PCR-4-ALL study group; MuSPAD study group |
| 28-Sep-2023 | VIDIIA Hunter: a low-cost, smartphone connected, artificial intelligence-assisted COVID-19 rapid diagnostic platform approved for medical use in the UK | Poirier, AC; Riaño Moreno, RD; Takaindisa, L; Carpenter, J; Mehat, JW; Haddon, A; Rohaim, MA; Williams, C; Burkhart, P; Conlon, C; Wilson, M; McClumpha, M; Stedman, A; Cordoni, G; Branavan, M; Tharmakulasingam, M; Chaudhry, NS; Locker, N; Fernando, A; Balachandran, W; Bullen, M; Collins, N; Rimer, D; Horton, DL; Munir, M; La Ragione, RM |
| 18-Feb-2021 | Years of life lost to COVID-19 in 81 countries | Pifarré i Arolas, H; Acosta, E; López-Casasnovas, G; Lo, A; Nicodemo, C; Riffe, T; Myrskylä, M |